GenSight Biologics S.A. (GSGTF)
OTCMKTS · Delayed Price · Currency is USD
0.1901
0.00 (0.00%)
At close: Aug 18, 2025
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of $30.38 million as of August 25, 2025. Its market cap has decreased by -18.98% in one year.
Market Cap
30.38M
Enterprise Value
49.84M
Revenue
2.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.19
Market Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 279.96M to 30.38M, a decrease of -89.15%. That is a compound annual growth rate of -21.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2025 | 30.38M | -11.21% |
| Dec 31, 2024 | 34.22M | 20.63% |
| Dec 29, 2023 | 28.37M | -82.90% |
| Dec 30, 2022 | 165.86M | -42.89% |
| Dec 31, 2021 | 290.43M | -21.99% |
| Dec 31, 2020 | 372.30M | 308.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 634.05M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.36M |
| Northwest Biotherapeutics | 366.64M |